Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 4 |
| List of Tables | 5 | 1 |
| List of Figures | 5 | 1 |
| Introduction | 6 | 1 |
| Global Markets Direct Report Coverage | 6 | 1 |
| P2X Purinoceptor 7 (P2Z Receptor or P2RX7) Overview | 7 | 1 |
| Therapeutics Development | 8 | 4 |
| P2X Purinoceptor 7 (P2Z Receptor or P2RX7) Products under Development by Stage of Development | 8 | 1 |
| P2X Purinoceptor 7 (P2Z Receptor or P2RX7) Products under Development by Therapy Area | 9 | 1 |
| P2X Purinoceptor 7 (P2Z Receptor or P2RX7) Products under Development by Indication | 10 | 2 |
| P2X Purinoceptor 7 (P2Z Receptor or P2RX7) Pipeline Products Glance | 12 | 2 |
| Late Stage Products | 12 | 1 |
| Early Stage Products | 13 | 1 |
| P2X Purinoceptor 7 (P2Z Receptor or P2RX7) Products under Development by Companies | 14 | 2 |
| P2X Purinoceptor 7 (P2Z Receptor or P2RX7) Therapeutics Assessment | 16 | 6 |
| Assessment by Monotherapy/Combination Products | 16 | 1 |
| Assessment by Mechanism of Action | 17 | 1 |
| Assessment by Route of Administration | 18 | 2 |
| Assessment by Molecule Type | 20 | 2 |
| P2X Purinoceptor 7 (P2Z Receptor or P2RX7) Companies Involved in Therapeutics Development | 22 | 6 |
| Affectis Pharmaceuticals AG | 22 | 1 |
| Axxam SpA | 23 | 1 |
| Biosceptre (Aust) Pty Ltd | 24 | 1 |
| Evotec AG | 25 | 1 |
| Johnson &Johnson | 26 | 1 |
| Medestea Research &Production S.p.A. | 27 | 1 |
| P2X Purinoceptor 7 (P2Z Receptor or P2RX7) Drug Profiles | 28 | 13 |
| AFC-5128 Drug Profile | 28 | 1 |
| BIL-010t Drug Profile | 29 | 1 |
| BIL-011t Drug Profile | 30 | 1 |
| BIL-03n Drug Profile | 31 | 1 |
| BIL-03s Drug Profile | 32 | 1 |
| BIL-04s Drug Profile | 33 | 1 |
| BIL-06v Drug Profile | 34 | 1 |
| BIL-07v Drug Profile | 35 | 1 |
| EVT-401 Drug Profile | 36 | 1 |
| JNJ-47965567 Drug Profile | 37 | 1 |
| MED-1101 Drug Profile | 38 | 1 |
| Small Molecule to Antagonize P2X7 Receptor for Central Nervous System Drug Profile | 39 | 1 |
| Small Molecules to Antagonize P2RX7 for CNS Disorders and Autoimmune Disorders Drug Profile | 40 | 1 |
| P2X Purinoceptor 7 (P2Z Receptor or P2RX7) Dormant Projects | 41 | 1 |
| P2X Purinoceptor 7 (P2Z Receptor or P2RX7) Discontinued Products | 42 | 1 |
| P2X Purinoceptor 7 (P2Z Receptor or P2RX7) Featured News &Press Releases | 43 | 3 |
| Dec 18, 2014: Alzheimer s Drug Discovery Foundation And Axxam Continue Their Successful Collaboration To Develop Novel Therapeutics For Alzheimer s Disease | 43 | 1 |
| Jul 22, 2014: Biosceptre Announces Positive Phase I Results for BIL-010t to Treat Basal Cell Carcinoma | 43 | 1 |
| Jan 25, 2012: Affectis Receives European Patent For AFC-5128 And Other P2X7 Antagonists | 44 | 1 |
| Jun 29, 2009: Evotec Announces The Successful Completion Of The First Phase I Study With EVT 401 | 44 | 1 |
| Oct 09, 2008: Evotec Announces Phase I Initiation With P2X7 Antagonist | 45 | 1 |
| Appendix | 46 | 2 |
| Methodology | 46 | 1 |
| Coverage | 46 | 1 |
| Secondary Research | 46 | 1 |
| Primary Research | 46 | 1 |
| Expert Panel Validation | 46 | 1 |
| Contact Us | 46 | 1 |
| Disclaimer | 47 | 1 |